title: Why both LC-MS/MS and FDA-compliant validation are essential for accurate estrogen assays?
authors: EndoCeutics Inc. Quebec City, Quebec, Canada. Electronic address: Fernand.labrie@endoceutics.com.
authors: Fernand
authors: F
authors: Labrie
authors: EndoCeutics Inc. Quebec City, Quebec, Canada.
authors: Yuyong
authors: Y
authors: Ke
authors: EndoCeutics Inc. Quebec City, Quebec, Canada.
authors: Renaud
authors: R
authors: Gonthier
authors: EndoCeutics Inc. Quebec City, Quebec, Canada.
authors: Alain
authors: A
authors: Bélanger
mesh_terms: D002853:Chromatography, Liquid / Q000379:methods / Q000592:standards; D004967:Estrogens / Q000097:blood*; D005260:Female; D006801:Humans; D008593:Menopause / Q000097:blood; D012015:Reference Standards; D053719:Tandem Mass Spectrometry / Q000379:methods / Q000592:standards; D014481:United States; D014486:United States Food and Drug Administration; D054928:Validation Studies as Topic
chemical_list: D004967:Estrogens
keywords: Estradiol; Mass spectrometry; Menopause; Validation